Skip to main content

Table 1 Patient characteristics and Quality of life rating

From: Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis

Group ADT n = 15 Control n = 15
Age 69.0 ± 5.3 y 66.1 ± 6.2 y
Education 9th grade: 1 9th grade: 1
  High School/GED: 5 High School/GED: 5
  College 1-3 years: 3 College 1-3 years: 3
  College graduate: 2 College graduate: 3
  Post-graduate: 4 Post-graduate: 3
MMSE 29.0 ± 1.3 29.5 ± 0.6
Cancer staging Stage II: 13 Stage I: 1
  Stage III: 2 Stage II: 12
   Stage III: 2
Local therapy Radiation 100% Radiation 26.7%
   Surgery 66.7%
   Surgery + Radiation 6.7%
QOL at baseline 115 ± 22 132 ± 18
QOL of life at 6 months 110 ± 23 128 ± 21
Testosterone at 6 months 0.14 ± 0.10 ng/ml 2.84 ± 0.94 ng/ml
  1. Note: ADT: Androgen Deprivation Therapy; GED: General Education Development Test; MMSE: Mini Mental State Examination; QOL: FACT-P quality of life score; there is no difference between groups in age (t = 1.172, p = 0.588, two-sided two-sample t test); there is no difference between groups in MMSE score (t = 1.417, p = 0.167, two-sided two-sample t test); staging follows the current guidelines of the 2010 American Joint Committee on Cancer (AJCC) that include Gleason score in the staging; there is also no difference across the two time points in the change of QOL between groups (F = 0.056, p = 0.814, interaction, repeated measures analysis of variance).
\